Finasteride and Minoxidil Combination Spray

finasteride, minoxidil and azelaic acid topical spray

Topical Complete Combination Spray

3 Month Supply

10% Minoxidil, 0.1% Finasteride, 2% Azelaic Acid

A complete formulation

A highly effective formulation designed for advanced hair support. This powerful triple combination works directly at the scalp to encourage hair growth, help reduce further thinning, and support a healthier scalp environment. With a high-strength 10% Minoxidil base and targeted DHT support, this spray is ideal for those looking for a stronger topical solution in one convenient formula.

Key Benefits
check_circleHigh-strength triple action formulation
check_circleEncourages growth while helping reduce ongoing thinning
check_circleFast-absorbing spray for targeted scalp application

One Time Purchase

£95
/ 3 month supply

Subscribe & Save

£85
/ 3 month supply

Online Consultation

Select Treatment

Free Express Delivery

Medically Reviewed by

Share This

Buy Minoxidil 10% + Finasteride 0.1% + Azelaic Acid for Hair Loss

Buy Minoxidil 10% + Finasteride 0.1% + Azelaic Acid, a high-potency topical treatment formulated for androgenetic alopecia. Minoxidil 10% + Finasteride 0.1% + Azelaic Acid combines three clinically backed ingredients that stimulate dormant hair follicles, block DHT production, and reduce scalp inflammation to slow shedding and restore density. Men and women experiencing pattern Hair Loss benefit from a prescription-grade concentration proven to deliver measurable regrowth results.

Secure a clinically backed solution that targets hair loss at the follicular level with a single daily application. Apply 1 mL to thinning areas, allow to dry, then style as normal. The formula combines the vasodilating power of minoxidil 10%, localised DHT suppression from Finasteride, and the anti-inflammatory benefits of Azelaic Acid.

Buy Minoxidil 10% + Finasteride 0.1% + Azelaic Acid today and take the first step toward fuller, healthier hair.

What are the Ingredients in Minoxidil 10% + Finasteride 0.1% + Azelaic Acid for Hair Loss?

The ingredients in Minoxidil 10% + Finasteride 0.1% + Azelaic Acid for hair loss are listed below:

  • Minoxidil 10%: A potent vasodilator that widens blood vessels around hair follicles, increasing nutrient and oxygen delivery to the scalp. The ingredient, at 10% concentration, extends the anagen (active growth) phase, stimulating dormant follicles to produce thicker and denser strands. Clinical studies report measurable regrowth in patients with moderate to advanced androgenetic alopecia after consistent daily use.
  • Finasteride 0.1%: A topical DHT-blocking agent that inhibits the Type II 5-alpha reductase enzyme responsible for converting testosterone into dihydrotestosterone (DHT). At 0.1% topical concentration, the ingredient suppresses localised DHT levels at the scalp without the systemic absorption associated with oral Finasteride tablets. The targeted delivery reduces follicle miniaturisation driven by excess DHT accumulation.
  • Azelaic Acid: A derived dicarboxylic acid that reduces scalp inflammation, sebum oxidation, and microbial activity linked to follicle damage. The ingredient addresses the inflammatory component of androgenetic alopecia, creating a healthier scalp environment for sustained hair regrowth. Research identifies Azelaic Acid as a mild 5-alpha reductase inhibitor, adding a complementary DHT-reducing effect to the formula.

1. Minoxidil 10%

Minoxidil 10% stimulates blood flow around hair follicles by widening the surrounding blood vessels, increasing the delivery of oxygen and nutrients to the scalp. The ingredient extends the anagen (active growth) phase, keeping follicles in active production longer. Consistent daily application supports measurable hair regrowth in thinning areas, with follicles producing visibly thicker and denser strands over time. The ingredient is a preferred choice for patients with moderate to advanced androgenetic alopecia requiring accelerated follicular stimulation because the vasodilating effect at 10% concentration is stronger than standard 5% formulations.

2. Finasteride 0.1%

Finasteride 0.1% acts as a localised DHT inhibitor, blocking the Type II 5-alpha reductase enzyme responsible for converting testosterone into dihydrotestosterone (DHT) at the scalp level. Reduced DHT concentration at the follicle slows hormonal-driven follicle miniaturisation, preserving existing hair density and reducing progressive thinning. Topical delivery at 0.1% concentration targets DHT suppression directly at the scalp, minimising systemic absorption compared to oral Finasteride tablets. Patients experiencing androgenetic alopecia driven by excess DHT accumulation benefit from the localised inhibition without the hormonal side effects associated with higher systemic doses.

3. Azelaic Acid

Azelaic Acid inhibits 5-alpha-reductase activity at the scalp level, complementing the DHT-blocking action of Finasteride within the formula. The ingredient supports overall scalp health by reducing inflammation and sebum oxidation linked to follicle damage. The combined DHT reduction at the follicle level creates a healthier scalp environment, reinforcing the anti-androgenic effects of Finasteride and slowing the hormonal progression of pattern hair loss. Derived from grains (wheat, barley, and rye), Azelaic Acid delivers antimicrobial and anti-inflammatory benefits that address the secondary scalp conditions, accelerating follicle miniaturisation.

Advantages of Using Minoxidil 10% + Finasteride 0.1% + Azelaic Acid Hair Loss Solution

The advantages of using the Minoxidil 10% + Finasteride 0.1% + Azelaic Acid hair loss solution are listed below.

  • Multi-Mechanism Hair Loss Combat: The formula targets hair loss across three distinct biological pathways, addressing blood flow restriction, DHT accumulation, and scalp inflammation simultaneously. Treating multiple root causes at once delivers faster and better comprehensive results than single-ingredient treatments.
  • Higher Minoxidil Strength for Accelerated Regrowth: Minoxidil delivers stronger vasodilation and follicular stimulation at 10% concentration than standard 5% formulations available over the counter. Patients with moderate to advanced androgenetic alopecia experience faster and denser regrowth at the higher concentration.
  • Topical Finasteride for Reduced Systemic Exposure: Finasteride at 0.1% topical concentration suppresses DHT directly at the scalp, avoiding the hormonal side effects linked to oral Finasteride tablets. The localised delivery method makes the formula a safer long-term option for daily use.
  • Clinically Backed Ingredients: Each active ingredient in the formula carries clinical evidence supporting its efficacy in treating androgenetic alopecia, setting it apart from standard over-the-counter products relying on unproven compounds.
  • Reduced Shedding: Consistent daily application slows the rate of hair shedding by addressing DHT-driven follicle miniaturisation at the scalp level.
  • Follicle Stimulation: Minoxidil 10% reactivates dormant follicles, extending the anagen phase and increasing the number of actively growing hair strands.
  • Hair Thickening: Improved blood flow and reduced DHT levels support the production of thicker, stronger hair strands in previously thinning areas.
  • Improved Scalp Health: Azelaic Acid reduces inflammation, sebum oxidation, and microbial activity, creating a healthier scalp environment that sustains long-term follicle function.

Side Effects

Side effects of the Topical Finasteride and Minoxidil Combination Spray are listed below:

  • Scalp Irritation or Scalp Burning: Scalp irritation or burning refers to a feeling of discomfort, redness, or a warm sensation on the scalp after applying the treatment. It may occur due to the active ingredients in the spray, leading to inflammation or sensitivity in the skin.
  • Scalp Red Dot: A scalp red dot is a small, localized area of redness on the scalp, resembling a pimple or spot. The reaction may be caused by the chemicals in the topical treatment, resulting in minor inflammation or clogged pores.
  • Scalp Itching: Scalp itching is a sensation of discomfort or a need to scratch the scalp after applying the product. The side effect may occur as a result of dry skin, irritation, or an allergic reaction to one or more ingredients in the spray.

Dosage

The recommended dosage for the Topical Finasteride and Minoxidil Combination Spray is once daily, applied to clean, dry areas of the thinning scalp. Wash and dry hands to apply, then spray directly onto the thinning areas and massage gently for even coverage. The spray requires 30 to 45 minutes for full absorption. Apply at night for optimal results, allow it to absorb during sleep (placing a towel over the pillow), and rinse in the morning, as recommended by Harley Street Hair Transplant Clinics. Each order provides a 3-month supply at the standard dose. Continued daily application is necessary to maintain hair density gains; discontinuing treatment results in a gradual return to pre-treatment hair loss patterns.

Conditions

The conditions addressed and the eligibility criteria for the Topical Finasteride and Minoxidil Combination Spray are listed below.

  • Androgenetic Alopecia (Male Pattern Hair Loss): The primary indication. The spray targets DHT-driven follicle miniaturisation across the vertex and frontal scalp, characteristic of Norwood stages 1 through 7.
  • Female Pattern Hair Loss: Topical Minoxidil is used in female androgenetic alopecia. The inclusion of topical Finasteride requires clinician assessment, as the hormonal mechanisms differ in males.
  • Progressive Hair Thinning: Patients experiencing diffuse thinning without complete follicle loss respond well to the vasodilatory and anti-androgenic dual mechanism of the spray.
  • Post-Hair Transplant Maintenance: The spray is suitable for use after FUE or FUT procedures to slow the progression of native hair loss in non-transplanted areas.
  • Eligibility Restrictions: Patients with a predisposition to depression, significantly low blood pressure, or taking medications that interact with 5-alpha reductase inhibitors require a clinician review before the spray is dispensed.

Requirements

The requirements for starting the Topical Finasteride and Minoxidil Combination Spray are listed below.

  • Online Consultation: Completing the eligibility questionnaire on the Harley Street Hair Transplant Clinics website is mandatory before any treatment is dispensed. A registered clinician reviews each submission.
  • Clinician Approval: The spray is a prescription-strength compounded treatment. Dispensing is conditional on the clinician determining the applicant is a suitable candidate.
  • Medical History Disclosure: Patients must disclose pre-existing conditions (low blood pressure, depression, liver conditions) and current medications to allow accurate eligibility assessment.
  • Age Requirement: Treatment is available to adults aged 18 and above.
  • Ongoing Prescription Renewal: Continued use beyond the initial 3-month supply requires a renewal of the prescription process through the clinic’s aftercare pathway.

Benefits

The benefits of the Topical Finasteride and Minoxidil Combination Spray are listed below.

  • Dual-Action DHT Suppression and Follicle Stimulation: The spray targets androgenetic alopecia at two biological pathways simultaneously. Finasteride blocks 5-alpha reductase locally, and Minoxidil expands blood vessels to increase nutrient and oxygen delivery to each follicle.
  • Reduced Systemic Exposure: The topical delivery route limits the absorption of Finasteride into systemic circulation compared to the oral 1mg tablet, reducing the likelihood of systemic side effects whilst retaining localised scalp activity.
  • Triple-Active Formulation: The addition of 2% Azelaic Acid provides a secondary DHT-inhibiting action and an anti-inflammatory effect at the scalp surface, reinforcing the Finasteride mechanism without additional systemic exposure.
  • Targeted Application: The spray format distributes the formulation evenly across thinning areas, ensuring each affected follicle receives consistent exposure to the active ingredients in each application.
  • Clinically Supported Actives: The Finasteride and Minoxidil combination recorded a Surface Under the Cumulative Ranking (SUCRA) score of 80.18%, ranking it as the most effective treatment in male subgroup analyses.
  • Suitable Across Stages of Hair Loss: The spray applies to early-stage and progressive androgenetic alopecia, making it a viable preventive measure as well as a treatment for established thinning.

How It Works

The topical Finasteride and Minoxidil Combination Spray for Hair Loss works by following the six steps listed below.

  1. Inhibit DHT Production: Finasteride (0.1%) inhibits 5-alpha reductase type II, the enzyme that converts testosterone into dihydrotestosterone (DHT) in the hair follicle. It prevents the progressive miniaturization of hair follicles by reducing scalp DHT concentrations by up to 64.1%, allowing them to remain active.
  2. Reduce Inflammation: Azelaic Acid (2%) acts as a partial 5-alpha reductase inhibitor and an anti-inflammatory agent, complementing Finasteride’s effects. It helps reduce inflammation on the scalp, preventing follicle regression and further hair loss.
  3. Increase Blood Flow: Minoxidil (10%) widens the blood vessels around the dermal papilla, improving blood flow. The increased blood volume delivers more oxygen and nutrients to the follicle, promoting hair growth.
  4. Prolong Hair Growth Phase: Minoxidil prolongs the anagen (growth) phase of the hair cycle and shortens the telogen (resting) phase. The results in denser, thicker hair as the follicles remain in the active growth phase longer.
  5. Stimulate Follicle Growth: The combined effects of Finasteride, Azelaic Acid, and Minoxidil stimulate existing follicles, encouraging the growth of healthier and stronger hair.
  6. Apply Once Daily: The three-ingredient spray is applied topically once daily to clean, dry areas of the scalp for ongoing follicle support and hair regrowth.

Why Choose Harley Street Hair Loss Solution?

Choose Harley Street Hair Loss Solution because every treatment is backed by clinically proven actives, dispensed through a GPhC-registered pharmacy, and reviewed by registered clinicians before it reaches the patient. Harley Street’s guiding principle is clinically proven hair restoration methods. No treatment is supplied without passing through an evidence-based eligibility review, ensuring patients receive formulations suited to their specific hair loss stage and medical profile.

The Topical Finasteride and Minoxidil Combination Spray is formulated under pharmaceutical compounding standards, guaranteeing the stability, sterility, and accurate dosing of each 3-month supply. The 10% Minoxidil base is the highest-strength topical concentration available in a compounded format, providing a more intensive follicle-stimulation response than the 2% and 5% concentrations available over the counter. The spray format delivers consistent scalp coverage across thinning areas with each application, unlike foam or liquid alternatives that can pool unevenly. Aftercare support is provided throughout the treatment period, with clinician check-ins available to monitor progress and adjust the approach. The Harley Street Hair Transplant Clinics provides the clinical infrastructure and pharmaceutical-grade products to support long-term hair loss management for patients seeking a localized, evidence-supported solution to androgenetic alopecia without the systemic exposure of oral medication.

What is the Importance of Choosing the Right Hair Loss Treatment?

The importance of choosing the right hair loss treatment determines whether androgenetic alopecia is slowed, stabilised, or allowed to progress unchecked. Androgenetic alopecia is a chronic, progressive condition driven by a combination of genetic predisposition and DHT sensitivity. Follicle miniaturisation continues across successive hair cycles until terminal hair production ceases permanently in affected areas without targeted pharmacological intervention. Early and accurate treatment selection is the decisive factor in preserving follicle viability.

A mismatched treatment (one that addresses only follicle stimulation without targeting DHT, or vice versa) delivers a partial response at best. The dual-mechanism approach combines a DHT inhibitor (Finasteride) with a vasodilator (Minoxidil). The strategy is the most clinically supported for androgenetic alopecia. It has a Surface Under the Cumulative Ranking Curve (SUCRA) ranking of 80.18% in the male subgroup network meta-analysis. The analysis was published in Frontiers in Medicine in 2025. Topical delivery is the preferred route for patients who require local scalp activity whilst minimising systemic hormonal exposure. Selecting the topical spray over an oral-only regimen reduces the concentration of Finasteride entering general circulation, making it a clinically appropriate option for patients sensitive to systemic hormonal changes. The correct treatment, started at the right stage of hair loss, preserves a greater number of viable follicles and extends the window of effective pharmacological management.

How is Topical Finasteride and Minoxidil Spray Delivered in the UK?

The Topical Finasteride and Minoxidil Spray is delivered across the UK by free express delivery from Harley Street Hair Transplant Clinics’ GPhC-registered pharmacy. Orders are dispatched once payment has been successfully processed and clinician approval has been confirmed. Standard UK delivery completes within 2 to 5 working days, and express delivery options are displayed at checkout where applicable. All orders are packaged discreetly to protect patient privacy. The external packaging provides no indication of the contents or the prescribing pharmacy.

The spray is a prescription-only medicine, meaning dispatch is contingent on the clinician’s eligibility review being passed. The 3-month supply is prepared and shipped by the registered pharmacy under pharmaceutical handling standards once approved. Patients receive confirmation of dispatch along with tracking information. The clinic operates Monday to Friday from 09:00 to 20:00 and Saturday to Sunday from 09:00 to 17:00, providing accessible contact points if delivery queries arise. Subscription orders follow the same dispatch process at each 3-month renewal, with reminder communications sent in advance of the next supply cycle.

What Is the Returns Policy for Prescription Hair Loss Treatments?

Prescription hair loss treatments (including the Topical Finasteride and Minoxidil Spray) are non-returnable once dispensed. Medicinal products that have been dispensed specifically for an individual patient cannot be accepted back, reused, or resold, even if the packaging remains unopened under UK pharmaceutical regulations and patient safety requirements. The Delivery, Returns and Refunds Policy at Harley Street Hair Transplant Clinics states that prescription-only medications and treatments dispensed specifically for the patient fall outside the standard returns framework.

Non-medicinal products (shampoos, supplements) purchased through the clinic are returnable within 14 days of delivery, provided the items are unused, unopened, and in their original packaging and in a resalable condition. Refunds are not issued once dispensing has occurred for prescription treatments specifically. The exception applies to faulty, damaged, or incorrectly sent items, which are assessed separately and may qualify for a replacement or full refund where a fault or error is confirmed by the support team. Patients who are uncertain whether a treatment is appropriate for them are encouraged to complete the online eligibility consultation thoroughly before proceeding, as the clinician review stage is the point at which suitability is confirmed.

What Should I Do If My Prescription Treatment Arrives Damaged?

You should notify Harley Street within 48 hours of delivery if your prescription treatment arrives damaged, faulty, or incorrect. The 48-hour notification window is specified in the clinic’s Delivery, Returns, and Refunds Policy and applies to all product types. Photographic evidence of the damage or fault is required as part of the assessment process. Patients should photograph the damaged item and the external packaging before making contact with the support team.

Contact must include the order number, a clear description of the issue, and the supporting photographs. The appropriate resolution is offered once the support team confirms the fault or error. A replacement order or a full refund, at the clinic’s discretion. Harley Street Hair Transplant Clinics covers reasonable return costs where a fault is confirmed on a prescription item. patients are not liable for return shipping on confirmed faulty or incorrectly dispatched prescription treatments. Use a tracked delivery service for any returns, as the clinic cannot accept liability for items lost in transit without tracking confirmation. The support team is reachable Monday to Friday from 09:00 to 20:00 and Saturday to Sunday from 09:00 to 17:00.

What are the Advantages of Using Topical Finasteride and Minoxidil Combination Spray Hair Loss Solution?

The advantages of the Topical Finasteride and Minoxidil Combination Spray are listed below.

  • Dual-Action Formula Targeting Hormonal and Follicle Stimulation Pathways: The spray addresses androgenetic alopecia at two distinct biological levels in a single daily application. Finasteride neutralises the DHT signal that drives follicle shrinkage, and Minoxidil simultaneously restores the vascular supply needed for active follicle growth, a combined approach with a SUCRA ranking of 80.18% in male subgroup analyses across randomised controlled trials.
  • Reduces Hair Shedding and Supports Visible Regrowth: Finasteride interrupts the miniaturisation cycle that shortens each hair’s active growth phase. Patients observe a measurable reduction in shedding from 3 to 6 months, with visible density improvements occurring from month 9 to 12 with consistent daily use.
  • Lower Systemic Exposure Compared to Oral Finasteride: Topical delivery limits the passage of Finasteride into general circulation. The 0.1% topical concentration reduces scalp DHT locally without the full systemic hormonal impact of the 1mg oral tablet, making the spray a suitable option for patients who are sensitive to systemic side effects.
  • Easy Spray Application for Targeted Scalp Coverage: The spray nozzle delivers the formulation precisely across thinning areas. The fast-absorbing formula penetrates the scalp within 30 to 45 minutes, making it practical for a nightly pre-sleep application routine.
  • Suitable for Early and Progressive Androgenetic Alopecia: The dual-mechanism formulation is effective at Norwood stages 2 through 7. Early-stage patients benefit from the preventive action of DHT suppression, while patients with established thinning benefit from Minoxidil’s follicle reactivation.
  • Clinically Supported Actives Used in Evidence-Based Hair Restoration Treatments: Minoxidil and Finasteride are the only two treatments with consistent, replicated evidence across randomised controlled trials and systematic reviews for androgenetic alopecia. Harley Street Hair Transplant Clinics supplies pharmaceutical-grade compounded formulations of both within a single spray.

What Makes Topical Finasteride and Minoxidil Spray an Effective Treatment for Male Pattern Baldness?

Targeting the two primary biological causes (Dihydrotestosterone, reduced blood flow to hair follicles) of androgenetic alopecia simultaneously makes Topical Finasteride and Minoxidil Spray an effective treatment for male pattern baldness. DHT-driven follicle miniaturization and reduced follicle blood supply contribute to male pattern baldness. The condition progresses through the action of DHT, which binds to androgen receptors in genetically susceptible follicles. It occurs across the vertex and frontal scalp. DHT shortens the anagen phase until the follicle produces only vellus (fine, colorless) hair each cycle, and the follicle becomes inactive.

Topical Finasteride (0.1%) blocks 5-alpha reductase type II at the scalp surface, reducing local DHT concentration. The topical route delivers comparable scalp-level DHT suppression at a lower systemic dose. Minoxidil (10%) complements the mechanism by widening dermal blood vessels at the follicle base, supplying the nutrients and oxygen that a hormonally stable follicle requires to resume and sustain active growth. The 10% topical concentration provides a stronger stimulus to the follicle blood supply than the 2% and 5% over-the-counter concentrations. The addition of 2% Azelaic Acid reinforces DHT inhibition and reduces scalp inflammation. The Finasteride and Minoxidil combination was the highest-ranked active treatment with a SUCRA score of 80.18% in the male subgroup of a network meta-analysis. It confirms its position as the most effective pharmacological approach for male pattern baldness in current evidence-based literature.

How does Topical Finasteride and Minoxidil Spray Support Hair Growth After FUE or FUT Hair Transplants?

Topical Finasteride and Minoxidil Spray supports hair growth after FUE or FUT hair transplants by protecting non-transplanted native follicles from progressive DHT-driven loss while improving the vascular environment across the treated scalp. A hair transplant relocates follicles from the donor area (typically the occipital scalp) to thinning recipient zones. The native follicles remaining in recipient zones continue to be susceptible to androgenetic alopecia if the underlying DHT activity is not managed.

The spray addresses the post-transplant patient’s two primary needs. First, Finasteride (0.1%) suppresses scalp DHT in the recipient area, reducing the hormonal signal that caused the original hair loss and protecting the remaining native follicles from further miniaturisation. The slow progression preserves density around the transplanted grafts. Second, Minoxidil (10%) improves blood supply across the scalp, delivering the oxygen and nutrient-rich circulation that newly implanted follicles require during the establishment phase. The vasodilatory effect supports graft survival by improving the local vascular environment in the weeks and months following surgery. Harley Street Hair Transplant Clinics spray is regularly used alongside FUE or FUT hair transplant to maintain existing hair and support long-term results. Clinician guidance on timing and frequency relative to the transplant procedure is provided as part of the aftercare support included with each treatment.

Can Topical Finasteride and Minoxidil Spray Be Used Alongside Other Hair Loss Treatments Offered at Harley Street?

Yes, the Topical Finasteride and Minoxidil Spray can be used alongside other hair loss treatments offered at Harley Street Hair Transplant Clinics, though the suitability of specific combinations is confirmed during the clinician eligibility review. The spray operates through topical delivery, which limits systemic overlap with oral treatments to a meaningful degree. Patients currently taking oral Minoxidil 2.5mg tablets or Finasteride 1mg tablets who are transitioning to or supplementing with the topical spray require clinician guidance on combined dosing to avoid exceeding the therapeutic threshold of either active ingredient.

The spray combines naturally with the clinic’s FUE and FUT hair transplant procedures as a post-surgical maintenance tool. It is a clinically appropriate option for patients who prefer to avoid oral treatment entirely. The clinic’s broader range of hair loss treatments (the Finasteride 1mg & Minoxidil 2.5mg Combination Capsules and standalone Minoxidil 2.5mg Tablets) operates through distinct delivery routes, and combinations are assessed individually by the reviewing clinician to ensure the patient’s total medication load is appropriate for their medical profile.

Can Using Topical Finasteride and Minoxidil Spray Increase Swelling After a Hair Transplant?

No, using Topical Finasteride and Minoxidil Spray cannot increase swelling after a hair transplant. Hair transplant swelling is not directly caused by Topical Finasteride and Minoxidil Spray. The application timing relative to surgery determines whether the spray plays any role in the post-operative inflammatory response. Swelling after a hair transplant (particularly in the forehead and periorbital area in the days immediately following the procedure) results from fluid accumulation at the surgical site following the micro-incisions made during graft insertion. The spray is not recommended for application in the acute post-operative phase (the first 7 to 14 days following surgery) without explicit clinician clearance.

Minoxidil’s vasodilatory mechanism dilates blood vessels and increases blood flow. The increased vascular activity carries a theoretical risk of amplifying localised swelling, applied to a freshly operated scalp still undergoing post-surgical inflammation. The clinic advises patients to follow post-operative care instructions, which include a specific timeline for reintroducing topical treatments. Finasteride in the spray does not itself cause swelling, as its mechanism is limited to enzymatic DHT suppression rather than vascular modulation. Patients with concerns about hair transplant swelling after reintroducing the spray should contact the Harley Street Hair Transplant Clinics aftercare team, who provide ongoing support throughout the recovery period.

Does Topical Finasteride and Minoxidil Spray Cause Scalp Itching After Hair Transplant Surgery?

No, Topical Finasteride and Minoxidil Spray does not cause scalp itching after hair transplant surgery. However, the alcohol-based carrier solution in compounded topical sprays can cause localised dryness or irritation if applied to a healing scalp before the surgical sites have fully closed. Itching in the weeks after FUE or FUT surgery is a normal part of the healing process, generated by the regeneration of nerve endings at the graft sites and the shedding of transplanted hairs (a process known as shock loss) in weeks 2 to 6 post-procedure.

Minoxidil’s propylene glycol component (used in many topical formulations as a carrier solvent) is a known cause of contact dermatitis and scalp irritation in a small number of patients. The risk is reduced where formulations are compounded without propylene glycol (as is possible in pharmaceutical compounding). Applying the spray to a scalp that has not yet healed fully from transplant surgery intensifies the drying effect of the carrier. Harley Street Hair Transplant Clinics provides specific aftercare timelines for reintroducing the topical spray following surgery. Patients experiencing hair transplant itching upon restarting the spray are advised to pause application and contact the aftercare team for guidance.

Do I Need a Consultation Before Starting Topical Finasteride and Minoxidil Spray?

Yes, you need a consultation before starting the Topical Finasteride and Minoxidil Spray. The spray contains Finasteride (a prescription-only medicine in the UK), meaning it cannot legally be dispensed without prior assessment and approval from a registered clinician. Harley Street Hair Transplant Clinics conducts the consultation through a structured online eligibility form that collects the patient’s medical history, current medications, hair loss stage, and relevant clinical risk factors.

A registered clinician reviews each submission before any treatment is dispensed. The review determines whether the applicant meets the eligibility criteria, whether the spray is the most appropriate formulation for their hair loss profile, and whether any contraindications (low blood pressure, depression, hormonal conditions) require further assessment before prescribing. The process is to be clear and not time-consuming. Verified customers confirm that the eligibility check was quick, thorough, and did not feel rushed. Patients approved through the process receive their prescription and a 3-month supply with free express delivery. Begin the process by completing the online eligibility check with Harley Street Hair Transplant Clinics is the first step.

Is Topical Finasteride and Minoxidil Spray a Prescription Treatment in the UK?

Yes, the Topical Finasteride and Minoxidil Spray is a prescription treatment in the UK. Finasteride (at any concentration) is classified as a prescription-only medicine (POM) under the UK Human Medicines Regulations 2012. Finasteride cannot be legally supplied without a valid prescription issued by a registered prescriber. Harley Street Hair Transplant Clinics operates as a GPhC-registered dispensing pharmacy (Registration No. 9011222), and every order of the topical spray is subject to mandatory clinician review and prescription approval before dispensing.

Minoxidil at concentrations above 5% is subject to prescription requirements in the UK when supplied as part of a compounded medicinal product. The 10% Minoxidil concentration in the spray falls above the 5% threshold available over the counter, reinforcing the prescription-only classification of the full formulation. Patients located in the UK complete an online eligibility consultation, receive a clinician-issued prescription upon approval, and the treatment is dispensed and delivered by the registered pharmacy. The prescription-only status protects patients by ensuring the formulation is supplied only for whom it is clinically appropriate.

Can Topical Finasteride and Minoxidil Spray Help Slow the Progression of Male Pattern Baldness?

Yes, the Topical Finasteride and Minoxidil Spray slows the progression of male pattern baldness by interrupting DHT-driven follicle miniaturisation and restoring the vascular conditions required for active follicle retention. Male pattern baldness progresses in a characteristic pattern from temple recession (Norwood Stage 2) through to extensive crown and frontal loss (Norwood Stages 6 and 7), with the rate of progression determined by genetic sensitivity to DHT and the degree of 5-alpha reductase activity in the scalp. Addressing the DHT signal early limits the extent of irreversible follicle loss.

Finasteride reduces scalp and serum DHT by approximately 60% to 70% and, with consistent use, produces notable regrowth effects at six months with sustained benefits over ten years. The spray’s topical delivery limits systemic exposure while achieving locally relevant DHT suppression at the follicle. Minoxidil’s vasodilatory action complements the DHT-blocking mechanism by keeping follicles metabolically active through improved blood supply. The combination slows progression measurably for patients in the earlier Norwood stages (2 to 4). The spray reduces the rate of further loss in the remaining native hair at more advanced stages (5 to 7), making it a relevant addition to any post-transplant maintenance plan.

How does Topical Finasteride and Minoxidil Spray Compare to Minoxidil Tablets?

Topical Finasteride and Minoxidil Spray is compared to Minoxidil Tablets by evaluating their effectiveness, side effects, and methods of action. The Topical Finasteride and Minoxidil Spray and Minoxidil Tablets (2.5mg oral) address androgenetic alopecia through the same vasodilatory Minoxidil mechanism. However, they differ substantially in delivery route, systemic exposure, additional active ingredients, and prescription scope. The topical spray provides the dual advantage of simultaneous DHT suppression and follicle stimulation, making it the more comprehensive option for androgenetic alopecia. A Minoxidil Tablet suits patients who prefer systemic delivery without the need for topical application or who cannot tolerate topical carrier solvents. Topical Finasteride and Minoxidil Spray and Minoxidil Tablets require clinician approval through Harley Street Hair Transplant Clinics before dispensing.

Is Topical Finasteride and Minoxidil Spray Suitable for Receding Hairlines?

Yes, the Topical Finasteride and Minoxidil Spray is suitable for receding hairlines at Norwood Stages 2 and 3, where frontal and temporal recession is active but follicle viability in the affected areas remains salvageable. A receding hairline in androgenetic alopecia results from DHT binding to androgen receptors in the frontal and temporal follicles, progressively shortening the hair cycle until terminal hair is no longer produced in those zones. Applying the spray to the hairline delivers both a DHT-inhibiting effect (Finasteride) and a growth-stimulating effect (Minoxidil) directly at the site of active loss.

The spray format is practical for targeting the hairline accurately, as the nozzle allows precise directional application along the anterior scalp margin without saturating surrounding areas. The earlier the hairline recession is treated, the greater the number of follicles that retain enough anagen-phase capacity to respond to Minoxidil’s vasodilatory stimulus. Patients in the later stages of frontal recession (Norwood Stages 5 to 7) retain fewer responsive follicles at the hairline, reducing the proportion of regrowth that Minoxidil alone achieves. The DHT-suppressing effect of Finasteride still contributes meaningfully to slowing further loss.

Is Topical Finasteride Safer Than Finasteride Tablets for Hair Loss?

Yes, topical Finasteride is safer than Finasteride Tablets for hair loss. The 1mg oral Finasteride tablet is fully absorbed through the gastrointestinal tract and enters systemic circulation at bioavailability rates ranging from 26% to 170% (mean 65%), producing measurable reductions in serum DHT of approximately 68.6% to 71.4%. The hormonal shift accounts for the side effects (reduced libido, mood changes, and erectile or ejaculatory dysfunction) reported in approximately 1 in 100 patients at the full systemic dose.

The 0.1% topical concentration in the spray is applied directly to the scalp, where it acts locally on the dermal follicle tissue. Systemic absorption through intact scalp skin is substantially lower than through the gastrointestinal tract, reducing the total Finasteride load entering circulation. The localized DHT suppression at the follicle remains clinically meaningful whilst the serum DHT reduction is more modest than with the oral route. The topical formulation offers a safer delivery profile for patients who have experienced side effects on Finasteride Tablets or who carry a predisposition to hormonal side effects. All prescribing decisions are made by the Harley Street clinician following the eligibility review.

Can Women Use Topical Finasteride and Minoxidil Spray for Female Pattern Hair Loss?

Yes, women can use Topical Finasteride and Minoxidil Spray for female pattern hair loss. Topical Minoxidil is an established treatment for female pattern hair loss, and the spray’s Minoxidil (10%) component acts on female follicles through the same vasodilatory mechanism it applies in male androgenetic alopecia. The topical route is preferred in women because systemic absorption of Finasteride carries specific risks for women of childbearing potential. Finasteride is a known teratogen and is contraindicated in pregnant women and women who may become pregnant. The lower systemic absorption of the 0.1% topical concentration reduces (but does not eliminate) the teratogenic exposure risk compared to the 1mg oral tablet.

Clinician assessment is mandatory before the spray is prescribed to female patients. The eligibility review evaluates hormonal profile, pregnancy status, contraceptive use, and the pattern of hair loss (Ludwig scale classification versus Norwood). Women with female pattern hair loss at Ludwig Stages I to III, who are not pregnant or planning a pregnancy, and who have received clinician clearance, represent the candidate group for whom the topical application of the combined formulation is clinically justifiable. Harley Street Hair Transplant Clinics assesses each female applicant individually through the online consultation to determine whether the spray or an alternative within the medication range is the appropriate treatment.

FAQs

This spray is designed to provide advanced support for hair thinning by encouraging regrowth, helping reduce further hair loss, and supporting overall scalp health. It works via the 2 active ingredients of finasteride and minoxidil.

Finasteride works via blocking the production of Dihydrotestosterone (DHT), the hormone that causes hair loss, giving your existing hair a chance to “recover” and grow.

Minoxidil works as a vasodilator meaning that increases the size of the blood vessels so that more blood can flow to the area. This provides nutrients and oxygen to encourage hair to thicken.

This highly effective spray contains 10% Minoxidil to stimulate hair growth, 0.1% Finasteride to help reduce DHT-related hair thinning, and 2% Azelaic Acid to support a healthier scalp environment and enhance overall effectiveness.

Firstly make sure you have washed your hands so that they are clean and dry. Then, apply the finasteride and minoxidil combo spray directly to clean, dry areas of the scalp once daily and massage it into the areas of hair thinning. Allow it to fully absorb before applying other products.

We recommend that you apply it at night just before you go to sleep as you will need to leave it in for approximately 30-45 minutes for it to be fully absorbed. You can then put a towel on your pillow and sleep whilst the solution is being absorbed and can then wash it off in the morning in the shower.

Finasteride works by blocking the production of the hormone Dihydrotestosterone (DHT for short). This hormone is a major contributor towards hair loss, specifically male pattern baldness in men. DHT miniaturises hair on the top of the head until they die off. Finasteride stop this from happening and thus promotes hair growth and thicknening.

Minoxidil is a vasodilator, meaning that it increases the size of the blood vessels in the area of application. This means that more blood flow occurs in the area bringing nutrients and oxygen to “feed” hairs and thus encouraging growth and thickness.

Azelaic acid works as part inhibitor of the enzyme 5-alpha reductase, which reduces the conversion of testosterone into dihydrotestosterone and part anti-inflammatory. This means that it helps along with finasteride in the blocking of the DHT hormone to promote more hair growth.

Results vary between individuals, but consistent use over 3 to 6 months is typically required before noticeable improvements are seen. A lot of our patients see significant results at month 9-12.

Yes, it is often used alongside other treatments or after hair transplant procedures to help maintain existing hair and support long-term results. Always follow professional guidance.

Like every medication, finasteride and minoxidil have possible side-effects. Around 1 in 100 men experience these side-effects however they dissipate after a few weeks of stopping use of the medication. Possible side effects of finasteride are:

  • low libido
  • mood changes
  • erectyle or ejaculation dysfunction.

Yes, Harley Street Hair Transplant Clinics provide aftercare guidance and ongoing support to help clients maintain and optimise their hair restoration results.

We are a hair transplant clinic that also provides hair loss medication to our patients as our motto is “clinically proven hair restoration methods” with topical finasteride and minoxidil combo spray being one of them, specifically a preventative method.

Complete spray review

Compare Our Treatments

See the key differences between our treatment options and choose the page that best matches your goals. Final suitability is determined through eligibility review.

Treatment Format Best for Key ingredients Usage Eligibility Pricing Action
Most Popular

Finasteride and Minoxidil Complete Capsules

Minoxidil 2.5mg + Finasteride 1mg + Biotin 10mg

Oral capsule Patients looking for a convenient all-in-one oral treatment option that combines key ingredients into a single daily capsule. Minoxidil 2.5mg, Finasteride 1mg, Biotin 10mg Once Daily Eligibility review required
£95 one-time £85 subscribe • 3 month supply
Recommended

Finasteride Tablets

Finasteride 1mg

Oral tablet Patients looking for a simple once-daily oral treatment focused on helping prevent further hair loss and supporting long-term hair maintenance. Finasteride 1mg Once daily Eligibility review required
£75 one-time £65 subscribe • 12 week supply
Recommended

Minoxidil Tablets

Minoxidil 2.5mg

Oral tablet Patients looking for a simple oral treatment option to support hair growth and hair retention as an alternative to topical application. Minoxidil 2.5mg Once daily Eligibility review required
£75 one-time £65 subscribe • 3 month supply
Alternative to Oral

Finasteride and Minoxidil Combination Spray

Minoxidil 10% + Finasteride 0.1% + Azelaic Acid

Topical spray Patients who prefer a topical treatment routine or want a non-tablet option as part of a clinician-led hair loss treatment plan. Minoxidil 10%, Finasteride 0.1%, Azelaic Acid 2% Once daily Eligibility review required
£95 one-time £85 subscribe • 3 month supply

Patient Results

J. Nuttall. Patient on the hair loss medication showing a before picture and a 9 months after consistent usage picture.

Name Undisclosed. Patient on the hair loss medication with a before image and a 10 months after consistent usage image.

Our Patient Reviews

I’ve been reordering my treatment for over 6 months now and the process is seamless. No stress, no delays, and reminders make it simple to stay consistent. It’s reliable, discreet and exactly what I needed.

James S
Customer

I had a few concerns before starting treatment, but the doctor was incredibly friendly and took the time to explain everything properly. I felt genuinely listened to and reassured. It’s rare to get that level of care online.

Sean V
Customer

I started using the finasteride and minoxidil treatment three months ago and the difference is honestly incredible. My hair looks noticeably thicker and I’ve stopped worrying every time I see a mirror. The whole process was straightforward and professional from start to finish. I only wish I’d started sooner.

Sam W
Customer

I was surprised at how quick and simple the eligibility check was. The online consultation was clear, thorough and didn’t feel rushed. I was approved quickly and my treatment arrived within a few days. It couldn’t have been easier.

Aman H
Customer